News
Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...
GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.
Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...
Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...
2d
Pharmaceutical Technology on MSNUK’s MHRA authorises GSK’s Blenrep for multiple myeloma treatmentThe UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...
2h
MyChesCo on MSNExpanded Recommendation for GSK’s AREXVY Vaccine Targets Adults at Higher Risk for Severe RSVThe Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory ...
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...
A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...
8h
MyChesCo on MSNCDC Panel Recommends GSK’s New PENMENVY Vaccine for AdolescentsThe U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results